iNOS Activity Is Required for the Therapeutic Effect of Mesenchymal Stem Cells in Experimental Systemic Sclerosis

Objectives: Fibrosis is a hallmark of systemic sclerosis (SSc), an intractable disease where innovative strategies are still being sought. Among novel anti-fibrotic approaches, mesenchymal stromal/stem cell (MSC)-based therapy appears promising. Previously, we reported anti-fibrotic effects of MSC i...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Immunol
Main Authors: Maria, Alexandre T. J., Rozier, Pauline, Fonteneau, Guillaume, Sutra, Thibault, Maumus, Marie, Toupet, Karine, Cristol, Jean-Paul, Jorgensen, Christian, Guilpain, Philippe, Noël, Danièle
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2018
Assuntos:
Immunology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6308989/
https://ncbi.nlm.nih.gov/pubmed/30622540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.03056
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares